Lipodystrophy and the Metabolic Consequences of Altered Fat Deposition Workshop, Lister Hill Auditorium, Bethesda, MD, Nov. 2-3, 2006   Lipodystrophy and the Metabolic Consequences of Altered Fat Deposition Workshop, Lister Hill Auditorium, Bethesda, MD, Nov. 2-3, 2006
Home Registration Agenda Hotel Logistics Abstract Submission Contact
 
(as of September 1, 2006 - subject to change)
 
Thursday, November 2, 2006
 
7:30 - 8:15 a.m. Registration and Continental Breakfast
 
8:15 - 8:30 a.m. Opening Remarks/Meeting Overview
 

 
Overview of Clinical Syndromes  
   
8:30 - 9:15 a.m. Overview of Clinical Syndromes of Lipodystrophies
Abhimanyu Garg, M.D., University of Texas Southwestern Medical Center at Dallas
   

 
   
Session I: Genetic Etiologies of Lipodystrophies
Moderator: Abhimanyu Garg, M.D.
   
9:15 - 9:45 a.m. Genetic Basis of Lipodystrophy and Obesity
Stephen O’Rahilly, M.D., F.R.S., University of Cambridge
   
9:45 - 10:15 a.m. 1-Acylglycerol-3-Phosphate-O-Acyl Transferase: An Update
Anil K. Agarwal, Ph.D., University of Texas Southwestern Medical Center at Dallas
   
10:15 - 10:45 a.m. Break
   
10:45 - 11:15 a.m. Update on the Role of Lamin A/C in Familial Partial Lipodystrophy
Howard Worman, M.D., Columbia University
   
11:15 - 11:45 a.m. Pathogenesis of NASH
Anna Mae Diehl, M.D., Duke University Medical Center
   
11:45 - 12:15 p.m. Hot Topic:
Genetic Etiologies of Berardinelli-Seip Congenital Lipodystrophy

Joycelyne Magre, Ph.D., Faculté de Médecine, Université Pierre et Marie Curie
   
12:15 - 2:00 p.m. Lunch (on your own) and Poster Session
   

   
Session II: Animal Models with Altered Fat Deposition
Moderator: Karen Reue, Ph.D.
   
2:00 - 2:30 p.m. Lipin and Adiposity
Karen Reue, Ph.D., University of California, Los Angeles
   
2:30 - 3:00 p.m. FAT-ATTAC Mice:  A Model of Inducible Lipoatrophy
Philipp Scherer, Ph.D., Albert Einstein College of Medicine
   
3:00 - 3:30 p.m. Phenotypic Characterization of 1-Acylglycerol-3-Phosphate Acyltransferase 2 Deficient Mice:  A Mouse Model of Congenital Generalized Lipodystrophy
Jay D. Horton, M.D., University of Texas Southwestern Medical Center at Dallas
   
3:30 - 4:00 p.m. Break
   
4:00 - 4:30 p.m. Lipodystrophy from Altered Adipose Triacylglycerol Metabolism
Hei Sook Sul, Ph.D., University of California at Berkeley
   
4:30 - 5:00 p.m. Role of MT1-MMP in 3D Development of WAT
Stephen J. Weiss, M.D., University of Michigan
   
5:00 - 5:30 p.m. Hot Topic:
Adipositis in the aP2-nSREBP-1c Mouse Model of Lipodystrophy

Laura Herrero, Ph.D., and Ali Nayer, M.D., Joslin Diabetes Center, Harvard Medical School, Boston
   
5:30 p.m Adjourn
   
   
   
   
Friday, November 3, 2006
   
7:30 - 8:30 a.m. Registration and Continental Breakfast
   

   
Session III: Clinical Investigations
Moderator: Phillip Gorden, M.D.
   
8:30 - 9:00 a.m. Adipose Tissue as an Endocrine Organ: The Role of Leptin Therapy in the Treatment of Lipodystrophy
Phillip Gorden, M.D., National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
   
9:00 - 9:30 a.m. Metabolic Alterations in HIV-Lipodystrophy: Clinical Consequences and Potential Treatment Strategies
Steven Grinspoon, M.D., Massachusetts General Hospital
   
9:30 - 10:00 a.m. Pathophysiology of Lamin and HIV-Related Lipodystrophies: Common Mechanisms
Jacqueline Capeau, M.D., Ph.D., Faculté de Médecine, Université Pierre et Marie Curie
   
10:00 - 10:30 a.m. Break
   

   
Session IV: The Life Cycle of the Adipocyte
Moderator: Bruce Spiegelman, Ph.D.
   
10:30 - 11:00 a.m. Role of PGC1α in Regulation of Metabolism
Bruce Spiegelman, Ph.D., Dana-Farber Cancer Institute/Harvard Medical Center
   
11:00 - 11:30 a.m. Adipocyte Apoptosis and Regulation of Fat Cell Mass
Clifton Baile, Ph.D., University of Georgia
   
11:30 - 12:00 p.m. C. elegans Fat Regulatory Networks
Kaveh Ashrafi, Ph.D., University of California, San Francisco
   
12:00 - 1:15 p.m. Lunch (on your own)
   
1:15 - 1:45 p.m. Sympathetic and Sensory Nerve Regulation of Adipose Tissue Growth
Timothy Jon Bartness, Ph.D., Georgia State University
   
1:45 - 2:15 p.m. The β-Catenin Antagonist Chibby Promotes Adipocyte Differentiation
Ken-Ichi Takemaru, Ph.D., State University of New York at Stony Brook
   
2:15 - 2:45 p.m. Elongation Factor 1A-1 in Lipotoxic Cell Death
Jean Schaffer, M.D., Washington University School of Medicine
   
2:45 - 3:15 p.m. Hot Topic:
PPARγldi: A Novel Mouse Model of Conditional Lipodystrophy

Yaacov Barak, Ph.D., The Jackson Laboratory
   
3:15 - 3:45 p.m. Closing Remarks
   
3:30 p.m. Adjourn
   
   
Lipodystrophy and the Metabolic Consequences of Altered Fat Deposition Workshop, Lister Hill Auditorium, Bethesda, MD, Nov. 2-3, 2006

Return to NIDDK Homepage.
This page last updated on 9/7/2006.
DHHS, NIH, DHHS